cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Applied Therapeutics Inc
7 own
13 watching
Current Price
$4.55
$0.1
(2.25%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
281.08M
52-Week High
52-Week High
9.39000
52-Week Low
52-Week Low
1.18000
Average Volume
Average Volume
2.78M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization281.08M
icon52-Week High9.39000
icon52-Week Low1.18000
iconAverage Volume2.78M
iconDividend Yield--
iconP/E Ratio--
What does the Applied Therapeutics Inc do?
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Read More
How much money does Applied Therapeutics Inc make?
News & Events about Applied Therapeutics Inc.
PR Newswire
12 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Applied Therapeutics, Inc. (NASDAQ: APLT) SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Applied Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Applied Therapeutics, Inc. for Potential Breaches of Fiduciary Duty...
Globe Newswire
1 year ago
Completed public equity offering with gross proceeds of $30 million Granted orphan medicinal product designation by the EMA for AT-007 for treatment of Galactosemia Continued progress in three registrational Phase 3 trials in areas of high unmet medical need, with multiple clinical milestones ...
Globe Newswire
2years ago
NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the Company), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the pricing of...
Globe Newswire
2years ago
NEW YORK, June 03, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced designation of AT-007 (...
Frequently Asked Questions
Frequently Asked Questions
What is Applied Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Applied Therapeutics Inc shares?
plus_minus_icon
How can I buy Applied Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Applied Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Applied Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Applied Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Applied Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Applied Therapeutics Inc?
plus_minus_icon
What percentage is Applied Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Applied Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.55
$0.1
(2.25%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00